As of November 10, 2026, Roivant Sciences Ltd. is a publicly traded company (Nasdaq: ROIV); its largest reported holder is Fidelity (FMR), with 11.8% on Schedule 13G/A of November 5, 2026, then BlackRock (8.2%). The largest insider holding is Vivek Ramaswamy, a 10% owner, with 47,011,612 shares (6.5% of shares outstanding), per Form 4 of December 15, 2025 (Schedule 13G/A, November 5, 2026).
Is this your company?
About to sign with, pay or invest in Roivant Sciences Ltd.? See the free Snapshot first.
Free to see. No signup.
Is Roivant Sciences Ltd. a real, registered company?
- Roivant Sciences Ltd. files with the SEC under CIK 1635088 (its SEC filings).
- Its shares are listed under the ticker ROIV on Nasdaq (SEC company record).
- Incorporated in D0, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under ROIVANT SCIENCES LTD in our court records and SEC 8-K records (as of 2026-11-10).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Fidelity (FMR) (filed 2026-11-05).
Who are Roivant Sciences Ltd.'s owners and officers?
Roivant Sciences Ltd.: industry Pharmaceutical Preparations (Schedule 13G/A, 2026-11-05).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-11-05 | Fmr LLC | 11.8% |
| Schedule 13G/A, 2026-10-27 | Blackrock, Inc. | 8.2% |
| Schedule 13G/A, 2026-08-13 | Morgan Stanley | 5.7% |
| Schedule 13G/A, 2026-05-12 | Morgan Stanley | 6.9% |
| Schedule 13G/A, 2026-05-06 | Ramaswamy Vivek | 3.6% |
| Schedule 13G/A, 2026-03-27 | The Vanguard Group | 0% |
| Schedule 13G/A, 2026-03-06 | Fmr LLC | 10.3% |
| Schedule 13G/A, 2026-02-17 | Sb Investment Advisers (Uk) Limited | 2.3% |
| Schedule 13G/A, 2026-02-13 | Ramaswamy Vivek | 6.8% |
| Schedule 13G/A, 2026-02-11 | Morgan Stanley | 8% |
| Schedule 13G/A, 2026-02-05 | Fmr LLC | 9.5% |
| Schedule 13G/A, 2025-11-14 | Viking Global Investors LP | 3.4% |
Questions about who owns Roivant Sciences Ltd.
Who owns Roivant Sciences Ltd.?
On this page, 3 holders' latest ownership filings report 5% or more of Roivant Sciences Ltd.: Fmr LLC (11.8%, Schedule 13G/A, filed 2026-11-05), Blackrock, Inc. (8.2%, Schedule 13G/A, filed 2026-10-27) and Morgan Stanley (5.7%, Schedule 13G/A, filed 2026-08-13).
Who are the largest shareholders of Roivant Sciences Ltd.?
By the share each holder's latest filing reports, the largest holders of Roivant Sciences Ltd. on this page are Fmr LLC (11.8%), Blackrock, Inc. (8.2%) and Morgan Stanley (5.7%).
When did Fmr LLC buy into Roivant Sciences Ltd.?
The filings give report dates, not purchase dates. The earliest filing from Fmr LLC on this page is the Schedule 13G/A, filed 2026-02-05, reporting 9.5%; its latest, Schedule 13G/A filed 2026-11-05, reports 11.8%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 12 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Roivant Sciences Ltd.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Roivant Sciences Ltd.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Roivant Sciences Ltd. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
18 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Which insiders own Roivant Sciences Ltd. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , a 10% owner: 47,011,612 shares (6.5% of shares outstanding), 33,653,755 held directly and 13,357,857 indirectly (Form 4, 2025-12-15).
- Roivant Sciences Ltd., a director and 10% owner: 29,880,079 shares (4.1% of shares outstanding) (Form 4, 2026-10-05).
- , the president and amp: 18,563,884 shares (2.6% of shares outstanding) (Form 4, 2026-10-20).
- , the chief executive and a director: 16,549,136 shares (2.3% of shares outstanding) (Form 4, 2026-10-20).
- QVT Financial LP: 13,689,166 shares (1.9% of shares outstanding), held indirectly through Held by QVT Financial Investment Cayman Ltd. (Form 4, 2026-06-30).
Shares outstanding: 724,561,460 as of 2026-11-03, from the company's latest SEC cover page.
How much has Roivant Sciences Ltd. raised?
No fundraising or offering filing from Roivant Sciences Ltd. is on file with us.
Keep reading
More on Roivant Sciences Ltd. and the records around it.
Roivant Sciences Ltd. elsewhere on the record
- 5%+ stake filings Nov 2026
Companies that share a holder
- Ramaswamy Vivek also filed stake reports on 2 other companies: Strive, Inc. (Oct 2026), BuzzFeed, Inc. (May 2026)
- QVT Financial LP also filed stake reports on 4 other companies: Allot Ltd. (Aug 2026), Real Asset Acquisition Corp. (Aug 2026), Comtech Telecommunications Corp. (May 2026)
- SB Investment Advisers (UK) Limited also filed stake reports on 5 other companies: Energy Vault Holdings, Inc. (May 2026), Vir Biotechnology, Inc. (May 2026), Compass, Inc. (Feb 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/roivant-sciences